MDH1的全景:驱动癌症进展和塑造瘤免疫微环境
Yunchen Lou1, Yunwei Lou2, Yao Cheng2
1Department of Respiratory, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuji, Zhejiang, China.
Frontiers in immunology
|September 15, 2025
概括
酸脱酶1 (MDH1) 在许多癌症中升高,与预后不佳有关. 准MDH1对癌症免疫疗法和肺腺癌治疗有希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 酸盐脱酶1 (MDH1) 是酸盐-酸盐运输中的一个关键酶.
- 跨癌症的MDH1表达与瘤微环境特征相关.
研究的目的:
- 进行MDH1.1的全面泛癌分析.
- 探索MDH1在癌症进展,免疫逃避和治疗向中的作用.
主要方法:
- 全癌症表达分析,临床相关性,遗传改变评估.
- 免疫基因组分析,单细胞动态,替代拼接和药物敏感性分析.
- 分子对接,肺腺癌 (LUAD) 的功能实验和免疫光测试.
主要成果:
- 在恶性瘤中,MDH1过度表达,与预后不佳相关.
- MDH1表达与免疫细胞透,特别是巨细胞,联系在一起,并预测免疫疗法反应.
- MDH1 knockdown 抑制了巨细胞的入侵;BI-2536,一种MDH1抑制剂,阻碍了LUAD细胞的生长.
结论:
- MDH1是癌症的潜在预后生物标志物.
- MDH1代表了癌症免疫治疗的有前途的治疗标.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


